3M Completes Sale of its Pharmaceuticals Business in Europe
3M announced it has completed its transaction with Meda AB for the sale of 3M's pharmaceuticals business in Europe. Under the agreement, Meda AB will acquire regional marketing and intellectual property rights for 3M's branded pharmaceuticals, including Aldara, Tambocor, MetroGel-Vaginal and Minitran.
The transactions with Ironbridge Capital and Archer Capital for the sale of 3M's pharmaceutical operations in the Asia Pacific region; and Graceway Pharmaceuticals LLC for the sale of 3M's pharmaceutical operations in the United States, Canada, and Latin America were completed in the fourth quarter of 2006.
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.